Identify Companies

 
News Articles for Identify Companies top ^
Genocea Biosciences, Inc. (NASDAQ: GNCA), a company developing T cell-directed vaccines and immunotherapies, today presented study results identifying a cluster of antigens that may be a biomarker of disease.
Sign-up for Genocea Profiles T cell Responses to Identify Antigens Associated with Malaria Episodes investment picks
QAD Inc. (NASDAQ:QADA) (NASDAQ:QADB), a leading provider of cloud enterprise resource planning (ERP) solutions and services for global manufacturers, announced today it has developed a solution for medical device manufacturers to help meet the Unique Device Identifier (UDI) rules as required by the Food and Drug Administration (FDA). The FDA issued a rule to establish a system to adequately identify devices through distribution and use.
Sign-up for QAD Prepares Unique Device Identifier Compliance Solution for Medical Device Manufacturers investment picks
2014/10/1
Corvus Gold Identifies Vein Shoot Target & Reports Phase I Results, North Extension Drilling, North Bullfrog Project, Nevada Canada NewsWire NB-14-399 Josh Vein Shoot Target: 9.4 metres @ 2.5 g/t Gold and 13.7 g/t Silver NB-14-395 New Zone - NW10 Target: 18.8 metres @ 1.2 g/t Gold and 3.5 g/t Silver & 9.6 metres of 1.1 g/t Gold and 6.4 g/t Silver TSX: KOR OTCQX: CORVF VANCOUVER , Oct.
Sign-up for Corvus Gold Identifies Vein Shoot Target & Reports Phase I Results, North Extension Drilling, North Bullfrog Project, Nevada investment picks
SAN FRANCISCO, Sept.
Sign-up for Pattern Energy Increases Identified ROFO List With Wind and Solar Projects investment picks
Foundation Medicine, Inc. (NASDAQ: FMI) today announced the presentation of new data from its ongoing collaboration with Clovis Oncology (NASDAQ: CLVS) to develop a novel companion diagnostic test to identify patients who have the potential to benefit from rucaparib, Clovis Oncology's poly (ADP-ribose) polymerase inhibitor (PARPi). These new data suggest that Foundation Medicine’s novel companion diagnostic can identify both BRCA-mutant patients and non BRCA-mutant patients who are more likely to benefit from rucaparib than patients who are biomarker negative.
Sign-up for Foundation Medicine’s Novel Companion Diagnostic Test, Developed in Collaboration with Clovis Oncology, Identifies Expanded Subgroup of Cancer Patients with the Potential to Respond to Clovis Oncology’s PARP inhibitor, Rucaparib investment picks
CyberArk (NASDAQ: CYBR), the company that protects organizations from cyber attacks that have made their way inside the network perimeter, today released a new report identifying the compromise and misuse of privileged accounts as a key signature common among advanced targeted cyber attacks.
Sign-up for CyberArk Releases Report Identifying New Patterns in Advanced Targeted Attacks investment picks
International Flavors & Fragrances Inc. (NYSE:IFF), a leading global creator of flavors and fragrances for consumer products, today announced that it has been identified as a leader in Climate Change Reporting and will be included in the Climate Disclosure Leadership Index (CDLI) compiled by the CDP (formerly known as the Carbon Disclosure Project). CDP is a not-for-profit organization working to transform the way the world does business to prevent climate change and protect the world’s natural resources.
Sign-up for IFF Identified As a Leader in Climate Change Reporting investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0973078001&sourceType=1 http://www.ccnmatthews.com/logos/20070525-mdn_200.jpg MONTREAL, QUEBEC --
Sign-up for MDN Identifies Three Large Exploration Targets on Samaqua investment picks
NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and molecular diagnostic products, today announced that the Journal of Clinical Oncology published an analysis of data in over 2,100 patients showing that the risk-of-recurrence (ROR) score generated by the PAM50-based Prosigna™ Breast Cancer Assay predicts the risk of late distant recurrence, after five years of endocrine therapy, in postmenopausal women with Hormone Receptor-Positive (HR+) early-stage breast cancer.
Sign-up for NanoString Announces Publication in the Journal of Clinical Oncology Showing the Prosigna Assay Identifies Women With a Low Risk of Late Distant Recurrence of Breast Cancer investment picks
Affymetrix (NASDAQ:AFFX) announced today the launch of Concurrent Molecular Analysis Profiling (CoMAP™) capability , which enables cancer researchers to gain rapid insight into the functional impact of DNA copy number alterations by combining whole-genome copy number data with gene expression profiles to easily and cost-effectively visualize and identify cancer driver events.
Sign-up for Affymetrix Launches Solution to Enable Cancer Researchers to Rapidly Map the Functional Impact of DNA Alterations on Gene Expression Profiles to Identify Potential Cancer Driver Events investment picks
RealD Inc. (NYSE: RLD), a leading global visual technology company, said today that it has identified $16 million in additional cost savings as it continues its efforts to streamline its organization and introduce additional efficiencies to its cost structure.
Sign-up for RealD Identifies $16 Million in Additional Expenditure Reductions investment picks
With the national open enrollment period in full swing and the Affordable Care Act (ACA) changing the health care insurance landscape, Paychex Insurance Agency , a wholly owned subsidiary of Paychex, Inc., has identified the top three reasons to consider enrolling in an individual insurance plan.
Sign-up for Paychex Insurance Agency Identifies Top Three Reasons to Consider Personal Marketplace investment picks
2014/9/24
By Jeremy Olshan, MarketWatch Why is iPhone 6 prone to bending?
Sign-up for UPDATE: Uri Geller identifies the real reason the iPhone 6 bends investment picks
2014/9/24
By Jeremy Olshan, MarketWatch Why is iPhone 6 prone to bending?
Sign-up for Uri Geller identifies the real reason the iPhone 6 bends investment picks
2014/9/23
As the global market for drugs surpasses $1 trillion this year, growing payer scrutiny of value for money is just one of the factors that will drive disruptive change in the use of medicines over the next decade, according to a report issued today by the IMS Institute for Healthcare Informatics.
Sign-up for IMS Health Identifies Ten Harbingers of Disruptive Change Forcing Adjustment to Healthcare Systems and Business Models investment picks
2014/10/1
NB-14-399 Josh Vein Shoot Target: 9.4 metres @ 2.5 g/t Gold and 13.7 g/t Silver NB-14-395 New Zone - NW10 Target: 18.8 metres @ 1.2 g/t Gold and 3.5 g/t Silver & 9.6 metres of 1.1 g/t Gold and 6.4 g/t Silver TSX: KOR OTCQX: CORVF VANCOUVER , Oct.
Sign-up for Corvus Gold Identifies Vein Shoot Target & Reports Phase I Results, North Extension Drilling, North Bullfrog Project, Nevada investment picks
2014/10/1
BT Assure Threat Defense combines cutting edge technology event monitoring and professional services IRVING, Texas , Oct.
Sign-up for BT Helps Customers Better Identify And React To Advanced Cyber Security Threats investment picks
2014/9/30
WARREN, N.J., Sept.
Sign-up for AdvantEdge Healthcare Solutions Identifies 7 Core Strategies for an Effective Compliance Program investment picks
2014/9/29
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0970054001&sourceType=1 http://media3.marketwire.com/docs/hartelogoLG.jpg TORONTO, ONTARIO --
Sign-up for Harte Gold Reports More High Grade Results at Wolf Zone, 17.8g/t Gold Over 3.1 Meters Extends Wolf Zone & Identifies Parallel Mineralized Sulphide Zones investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Identify Companies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: IDEAS Investor Conference  |  Next: IGM Financial